menu
Your Cart

ITA8933

ITA8933-1
ITA8933-2
ITA8933-3
ITA8933-1
ITA8933-2
ITA8933-3
ITA8933
  • Catalog: ITA8933
  • Gene/Protein: ACER1
  • Product Description: Immunotag™ ASAH3 Antibody
385.0000
Price in reward points: 385

Available Options

Immunotag™ ASAH3 Antibody
Antibody Specification
Datasheet

Target Protein ASAH3
Clonality Polyclonal
Storage/Stability -20°C/1 year
Application WB,IF/ICC,ELISA
Recommended Dilution WB 1:1000-3000, IF/ICC 1:100-1:500
Concentration 1 mg/ml
Reactive Species Human
Host Species Rabbit
Immunogen A synthesized peptide derived from human ASAH3
Specificity ASAH3 Antibody detects endogenous levels of total ASAH3
Purification The antiserum was purified by peptide affinity chromatography.
Form Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt
Gene Name ACER1
Accession No. Q8TDN7
Alternate Names Acer1; ACER1_HUMAN; Acylsphingosine deacylase 3; Alkaline CDase 1; Alkaline ceramidase 1; Alkaline ceramidase; AlkCDase 1; ALKCDase1; ASAH 3; MGC138327; MGC138329; N acylsphingosine amidohydrolase (alkaline ceramidase) 3; N acylsphingosine amidohydrolase 3 alkaline ceramidase; N acylsphingosine amidohydrolase 3; N-acylsphingosine amidohydrolase 3;
Description Hydrolyzes the sphingolipid ceramide into sphingosine and free fatty acid at an optimal pH of 8.0. Has a highly restricted substrate specificity for the natural stereoisomer of ceramide with D-erythro-sphingosine but not D-ribo-phytosphingosine or D-erythro-dihydrosphingosine as a backbone. May have a role in regulating the levels of bioactive lipids ceramide and sphingosine 1-phosphate, as well as complex sphingolipids (By similarity).
Cell Pathway/ Category Primary Polyclonal Antibody
Protein MW 31 kDa
Usage For Research Use Only! Not for diagnostic or therapeutic procedures.
Material Safety Data Sheet
English_US
Danish
Dutch
English_UK
French
German
Spanish
Norwegian
Portuguese
Finnish
Swedish
Polish

Write a review

Note: HTML is not translated!
Bad Good
Captcha

CONNECT WITH US